BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26714663)

  • 1. Early treatment of complex located pediatric low-grade gliomas using iodine-125 brachytherapy alone or in combination with microsurgery.
    Kunz M; Nachbichler SB; Ertl L; Fesl G; Egensperger R; Niyazi M; Schmid I; Tonn JC; Peraud A; Kreth FW
    Cancer Med; 2016 Mar; 5(3):442-53. PubMed ID: 26714663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept.
    Schnell O; Schöller K; Ruge M; Siefert A; Tonn JC; Kreth FW
    J Neurol; 2008 Oct; 255(10):1495-502. PubMed ID: 18677635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial iodine-125 radiosurgery alone or in combination with microsurgery for pediatric patients with eloquently located low-grade glioma: a pilot study.
    Peraud A; Goetz C; Siefert A; Tonn JC; Kreth FW
    Childs Nerv Syst; 2007 Jan; 23(1):39-46. PubMed ID: 16972111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas.
    Watson J; Romagna A; Ballhausen H; Niyazi M; Lietke S; Siller S; Belka C; Thon N; Nachbichler SB
    Radiat Oncol; 2020 Dec; 15(1):275. PubMed ID: 33298103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
    Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
    Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
    Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
    J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
    Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
    Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic brachytherapy of low-grade cerebral glioma after tumor resection.
    Suchorska B; Ruge M; Treuer H; Sturm V; Voges J
    Neuro Oncol; 2011 Oct; 13(10):1133-42. PubMed ID: 21868412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome.
    Ruge MI; Kickingereder P; Simon T; Treuer H; Sturm V
    J Neurooncol; 2012 Sep; 109(2):273-83. PubMed ID: 22580799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-125 brachytherapy as upfront and salvage treatment for brain metastases : A comparative analysis.
    Romagna A; Schwartz C; Egensperger R; Watson J; Tonn JC; Belka C; Kreth FW; Nachbichler SB
    Strahlenther Onkol; 2016 Nov; 192(11):780-788. PubMed ID: 27349709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
    Hadi I; Reitz D; Bodensohn R; Roengvoraphoj O; Lietke S; Niyazi M; Tonn JC; Belka C; Thon N; Nachbichler SB
    Radiat Oncol; 2021 Feb; 16(1):40. PubMed ID: 33622365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of brachytherapy with temporary iodine-125 seeds in children with low-grade gliomas.
    Korinthenberg R; Neuburger D; Trippel M; Ostertag C; Nikkhah G
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1131-8. PubMed ID: 20510544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
    Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
    BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.
    Suchorska B; Hamisch C; Treuer H; Mahnkopf K; Lehrke RE; Kocher M; Ruge MI; Voges J
    J Neurooncol; 2016 Oct; 130(1):123-131. PubMed ID: 27422129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas.
    Videtic GM; Gaspar LE; Zamorano L; Fontanesi J; Levin KJ; Kupsky WJ; Tekyi-Mensah S
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):687-92. PubMed ID: 10524423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial radiosurgery of low-grade gliomas.
    Kreth FW; Faist M; Warnke PC; Rossner R; Volk B; Ostertag CB
    J Neurosurg; 1995 Mar; 82(3):418-29. PubMed ID: 7861220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.
    El Majdoub F; Neudorfer C; Blau T; Hellmich M; Bührle C; Deckert M; Sturm V; Maarouf M
    Strahlenther Onkol; 2015 Dec; 191(12):936-44. PubMed ID: 26307628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine-125 interstitial irradiation for cerebral gliomas.
    Ostertag CB; Kreth FW
    Acta Neurochir (Wien); 1992; 119(1-4):53-61. PubMed ID: 1481753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
    Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
    Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis.
    Raleigh DR; Seymour ZA; Tomlin B; Theodosopoulos PV; Berger MS; Aghi MK; Geneser SE; Krishnamurthy D; Fogh SE; Sneed PK; McDermott MW
    J Neurosurg; 2017 Jun; 126(6):1749-1755. PubMed ID: 27367240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.